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To assess whether spontaneous coronary artery spasm in intravenous ergonovine, luminal diameter of spastic seg 
patients with variant angina results from local coronary ments was reduced by 91.5%, that of nonspastic proximal 
hyperreactivity to a generalized constrictor stimulus or segments by 17.8% and that of nonspastic distal segments 
from a stimulus generated only at the site of the hyperre- by 11.5%. Luminal diameter of unrelated arteries during 
active segment, the behavior of spastic and nonspastic ergonovine-induced spasm was reduced by 17.7%. Con- 
coronary segments was studied in six patients with variant striction of spastic segments was greater during ergonovine- 
angina in whom focal coronary spasm developed spontane- induced spasm (p < 0.05), whereas the extent of diameter 
ously during cardiac catheterization. None of the patients reduction of nonspastic segments was not significantly 
had critical @-SO% huninal diameter reduction) organic different during spontaneous spasm and ergonovine- 
coronary stenoses. Coronary diameters were measured by induced spasm. Intracoronary isosorbide din&ate dilated 
computerized quantitative arteriography during control, spastic and nonspastic coronary segments to a similar 
spontaneous spasm and ergonovine-induced spasm and extent from control (20.7%, 18% and 16.5%, respectively; 
after intracoronary nitrates were given. p = NS). 
During spontaneous spasm, the huninal diameter of 
spastic and both proximal and distal nonspastic coronary 
segments was significantly reduced from control values, 
64.2%, 13.2% and 14.8%, respectively. Average diameter 
reduction of unrelated arteries was 12.3%. Ergonovine, 
which was also administered to four patients, provoked 
focal spasm at the same site as spontaneous spasm. During 
This study demonstrates that spontaneous focal coro- 
nary spasm in variant angina results from a local exagger- 
ated coronary constrictor response to a generalized stimu- 
lus that produces only mild constriction in other coronary 
segments. 
(J Am Coil Cardiol1989;14:1456+53) 
Although coronary artery spasm was considered to be a 
proved hypothesis more than a decade ago (l), its causes are 
still incompletely understood. We (2) have shown that er- 
gonovine causes focal coronary artery spasm in patients with 
variant angina by a direct local coronary effect while pro- 
ducing only mild constriction on other segments of the 
spastic artery and adjacent branches. This local hyperreac- 
tivity in variant angina does not appear to be specific for a 
single type of agonist-receptor interaction, because spasm 
can be induced by a variety of stimuli acting through 
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different receptors (3). It is not known, however, whether 
coronary spasm that occurs spontaneously also results from 
a local coronary hyperreactivity to a generalized constrictor 
stimulus affecting the coronary arteries diffusely or just from 
a localized stimulus generated at the site of the hyperreactive 
segment. To address this question we analyzed the behavior 
of spastic and nonspastic coronary artery segments during 
episodes of spontaneous coronary spasm observed during 
angiography in six patients with variant angina. 
Methods 
Study patients. From 1982 to 1987, 58 patients with the 
syndrome of Prinzmetal’s variant angina underwent cardiac 
catheterization in our institution. Of these, six (five men, one 
woman; mean age 50 ? 7 years) developed coronary spasm 
spontaneously during cardiac catheterization and are the 
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Table 1. Clinical and Angiographic Characteristics of Six Patients With Variant Angina 
Angina ECG 
Baseline Coronary 
Patient 
No. 
Age (yr) 
& Gender Type 
Onset 
(mo) Basal 
During Spontaneous 
Angina 
During 
Ergonovine* 
Angiography 
(% stenosis) 
I 49F 
2 54M 
3 55M 
4 47M 
5 58M 
6 38M 
EtR 12 Normal ST? VI-V, STT VI-V, LAD 35% 
R 72 Normal ST t II.lll.aVF ST t II.IIl,aVF LCx 30%; RCA 14% 
R 6 Normal ST t II,IIl.aVF ST t II.III,aVF LAD 12%; RCA 21% 
R 4 Normal ST T II.III.aVF ST 7 II.Ill,aVF LCx 30%; RCA 42% 
R 24 Normal ST 1 V>-V, ST t V2-V, LAD 1 I%; RCA 40% 
R 7 Normal STI Vz-V, ST J V2-V, LMS 40%; LAD 32% 
*Performed in the noninvasive laboratory. E = effort: ECG = electrocardiogram; F = female; LAD = left anterior descending coronary artery: LCx = left 
circumflex coronary artery: LMS = left main stem; M = male: R = rest; RCA = right coronary artery; ST = ST segment; J = depression: T = elevation. 
subject of this report. All six patients had a history typical of 
variant angina, with angina1 episodes at rest, usually at night 
and in the early morning hours, but with preserved exercise 
capacity. Angina1 episodes were associated with transient 
ST segment elevation (five patients) or depression (one 
patient). documented by ambulatory electrocardiographic 
(ECG) monitoring. Since the onset of the syndrome of 
variant angina, these patients had had periods of spontane- 
ous waxing and waning of the disease. Although at admis- 
sion all patients were in an active phase of their variant 
angina, with one to eight angina1 episodes (mean 2.8 epi- 
sodes/patient) in the week preceding admission, angina1 
attacks were usually short-lasting and resolved spontane- 
ously within 3 min or were promptly relieved by sublingual 
nitrates in all cases. The clinical and angiographic charac- 
teristics of the patients are summarized in Table 1. 
Ergonovine provocative testing. Each patient underwent 
provocative testing in the noninvasive laboratory with incre- 
mental doses of ergonovine and 12 lead ECG monitoring, 
using a protocol described in detail elsewhere (3). During 
intravenous ergonovine administration, all patients had their 
usual angina1 pain, which was associated with marked ST 
segment elevation in five patients and ST segment depres- 
sion in one patient, thus reproducing findings during spon- 
taneous angina1 episodes (Table I). Ergonovine-induced 
myocardial ischemia was completely reversed within 60 s by 
intravenous isosorbide dinitrate. 
Cardiac catheterization. Every patient gave written in- 
formed consent for coronary arteriography and administra- 
tion of ergonovine during cardiac catheterization. The study 
protocol was approved by the Hammersmith Hospital Ethics 
Committee. 
Use of antianginal medications was discontinued at least 
48 h before cardiac catheterization, with the exception of 
sublingual nitrates, which were administered as needed. 
Patients were studied in the fasting state, received no 
premeditation and had not smoked or taken sublingual 
nitrates in the 6 h preceding coronary arteriography. The 
Judkins technique was used in all patients. Baseline diagnos- 
tic (control) coronary angiograms were obtained in Patients 
1, 2, 3, 4 and 5. In these five patients chest pain developed 
spontaneously 1 to 3 min after baseline coronary angiogra- 
phy and was associated with ischemic ST segment changes 
in four (Patients 1 through 4). Angiography of the appropri- 
ate coronary artery was immediately performed and demon- 
strated nonocclusive focal coronary spasm in all cases. The 
coronary artery to receive an injection during spontaneous 
chest pain was selected on the basis of either ECG changes 
observed during monitoring at angiography (Patients 1 
through 4) or the result of the ergonovine test previously 
performed in the noninvasive laboratory (Patient 5). In 
Patient 6, ischemic ST segment changes in the anterior leads 
and chest pain developed spontaneously before diagnostic 
coronary angiography was performed. Left coronary arteri- 
ography revealed focal coronary spasm of both the left 
anterior descending coronary artery and left main stem. 
Coronary angiography was repeated without therapy in this 
patient within 1 week of the previous study to obtain further 
information for clinical management and this second coro- 
nary arteriogram was used as control. Patients were not kept 
in the catheterization laboratory until spontaneous coronary 
spasm developed. As described earlier, spasm developed by 
chance 1 to 3 min after completion of baseline coronary 
angiograms in Patients 1 to 5 and before baseline angiogra- 
phy in Patient 6. 
Ergonovine testing during cardiac catheterization. In four 
patients (Patients 1, 3, 4 and 5), coronary spasm resolved 
spontaneously within 60 s. These four patients then under- 
went provocative testing with incremental doses of intrave- 
nous ergonovine (3) during cardiac catheterization, which 
provoked focal spasm in all four. Ergonovine-induced spasm 
was promptly reversed by intracoronary isosorbide dinitrate 
(1 to 3 mg) in all four cases. In Patient 2, in whom spasm did 
not resolve spontaneously within 1 min, and in Patient 6, 
who had spasm of both the left anterior descending artery 
and left main stem, intracoronary isosorbide dinitrate (2 mg) 
was immediately given, with prompt resolution of spasm in 
both cases. These two patients were not administered er- 
gonovine during cardiac catheterization. Angiograms were 
also obtained during ergonovine testing in Patients 1, 3, 4 
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Figure 1. Coronary segments considered for computer analysis in 
the three patients with spasm of the left anterior descending artery 
(left panel) and the three patients with spasm of the right coronary 
artery (right panel). Spastic coronary segments (arrows) and non- 
spastic segments (boxes) were identified. Intraluminal diameter of 
every coronary segment considered for analysis was measured by 
computerized quantitative arteriography from angiograms obtained 
during control, spontaneous spasm and ergonovine-induced spasm 
and after administration of intracoronary nitrates. 
and 5, and after administration of intracoronary nitrates in all 
patients. 
Coronary diameter measurements. During coronary angi- 
ography, the rotation and skew angles, height and magnifi- 
cation factors of the X-ray image intensifier were not altered 
so that comparable arteriograms were obtained before, dur- 
ing and after spontaneous spasm or provocations. Our 
technique to measure coronary artery diameters has been 
reported in detail previously (2). Briefly, coronary luminal 
diameters were measured by an automated edge contour 
detection computerized system (Coronary Angiography 
Analysis System [CAAS], Pie Data Medical). The size of the 
stem of the Judkins coronary catheter was used for calibra- 
tion to absolute measurement units in millimeters and cor- 
rection was made for radiographic pincushion distortion. 
Coronary arteriograms were analyzed by two independent 
observers and blindly reanalyzed at a remote time for 
reproducibility of the method. No significant difference in 
the variances between analyses was found. 
Coronary segments considered for measurement are 
schematically shown in Figure 1. In the spastic vessel, the 
spastic segment as well as one proximal and one distal 
nonspastic segment were analyzed. Proximal and distal 
coronary segments of the nonspastic circumflex artery were 
also analyzed when spasm developed in the left anterior 
descending coronary artery. Narrowed segments that did not 
change in diameter after administration of intracoronary 
nitrates at the end of the study were considered “fixed” 
stenoses. 
Data analysis. Minimal luminal diameter of spastic and 
nonspastic coronary segments at baseline angiography (in 
the absence of chest pain or ECG changes), during sponta- 
neous spasm and ergonovine-induced spasm and after ad- 
ministration of nitrates was measured in millimeters. Results 
are expressed as mean values + 1 SD of the absolute values 
of the minimal luminal diameter at the site of spastic and 
nonspastic segments. Changes in coronary caliber of spastic 
and nonspastic segments are expressed as percent change 
relative to control values. Paired and unpaired t tests were 
used, as appropriate, to analyze changes in luminal diame- 
ter. A p value < 0.05 was considered statistically significant. 
Results 
Baseline angiography. In no cases were severe (>50% 
luminal diameter reduction) coronary atheromatous obstruc- 
tions observed during baseline angiography, although pa- 
tients had organic coronary stenoses ranging from 11% to 
42% diameter reduction (Tables 1 and 2). During control 
arteriography, the luminal diameter of segments that devel- 
oped spasm was 2.19 +- 0.49 mm, whereas luminal diameters 
of proximal and distal nonspastic segments were 3.39 ? 0.74 
and 2.79 + 0.43 mm, respectively (Tables 3 and 4). 
Spontaneous coronary spasm. Angina and ischemic ST 
segment changes that occurred in association with coronary 
spasm during cardiac catheterization developed when no 
catheter manipulations or contrast injections were being 
carried out. Spontaneous nonocclusive focal spasm devel- 
oped at the site of mild atheromatous coronary stenoses 
Table 2. Coronary Spasm During Cardiac Catheterization: Symptoms and Electrocardiographic 
Changes in Six Patients 
Patient 
No. 
Spastic Segment 
(% fixed stenosis) 
Spontaneous Spasm 
Angina ECG Changes 
Proximal LAD (35%) 
Mid-RCA (14%) 
Mid-RCA (21%) 
Mid-RCA (42%) 
Mid-LAD (11%) 
Proximal LAD (32%); 
and LMS (40%) 
t ST 4 V,-V, 
t ST 7 II,III,aVF 
t ST t II,III,aVF 
t ST J II,III,aVF 
t* Nil 
t STf V,-V5 
Ergonovine-induced Spasm 
Angina ECG Changes 
t ST? V,-V, 
ND ND 
t ST t II,III,aVF 
t ST t II,III,aVF 
t ST t V,V, 
ND ND 
*Mild chest discomfort; t = present; ND = ergonovine test not done; other abbreviations and symbols as in 
Table 1. 
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Table 3. Changes in Luminal Diameter of Spastic Coronary Segments During Spontaneous Spasm, 
Ergonovine-induced Coronary Spasm and After Intracoronary Nitrates in Six Patients _ 
Patient Control 
Spontaneous Spasm Ergonovine Isosorbide Dinitrate 
No. (mm) mm % Change mm % Change mm % Change 
1 2 
2 3.07 
3 2.3 
4 1.57 
5 2.1 
6 2.1 
Mean 2.19 
SD 0.49 
091 -55 0 -100 
0.67 -78 ND ND 
0.46 -80 0 -100 
0.98 -38 0.54 -66 
I .03 -51 0 -100 
0.35 -83 ND ND 
0.73 -64.17 0.14 -91.50 
0.28 18.65 0.27 17.00 
2.14 7 
3.67 19 
2.48 7 
2.64 68 
2.23 6 
2.45 17 
2.60 20.67 
0.55 23.86 
Negative values indicate percent reduction of coronary luminal diameter. ND = not done; SD = standard 
deviation. 
(range 11% to 42% diameter reduction) in all cases. How- 
ever, fixed stenoses of a similar severity were also present in 
coronary segments that did not develop spasm (Table 1). 
Spontaneous spasm occurred in the left anterior descending 
coronary artery in Patients 1 and 5, in the right coronary 
artery in Patients 2, 3 and 4 and simultaneously in both the 
left anterior descending artery and left main stem (60% 
luminal diameter reduction) in Patient 6 (Table 2). 
Spontaneous coronary spasm was associated with angina 
and transient ischemic ST segment changes in five patients 
and with only minor chest discomfort in 1 patient (Patient 5) 
(Table 2). Myocardial ischemia subsided spontaneously 
within 60 s in four patients and resolved immediately after 
intracoronary isosorbide dinitrate (2 mg) in two. Angina 
during spontaneous spasm was associated with ST segment 
elevation in Patients 2, 3 and 6 and with ST segment 
depression in Patients 1 and 4. Patient 5 had mild chest 
disconfort and no ischemic ST segment changes (Table 2). 
Ergonovine-induced spasm. Ergonovine, which was ad- 
ministered to four patients during cardiac catheterization, 
provoked occlusive focal spasm at the same site as sponta- 
neous coronary spasm in all four cases (Table 2). Er- 
gonovine-induced spasm was associated with angina and ST 
segment elevation in all four patients (Table 2); prompt 
resolution of ergonovine-induced spasm followed the intra- 
coronary administration of isosorbide dinitrate in all cases. 
Behavior of spastic segments. During spontaneous spasm 
mean coronary diameter of spastic segments was reduced by 
64.2 f 18.6% from control (from 2.19 f 0.49 to 0.73 k 0.28 
mm: p < 0.001) (Table 3, Fig. 2 and 3). The degree of luminal 
diameter reduction observed at the site of spastic segments 
during spontaneous spasm significantly exceeded that pre- 
dicted by the geometric theory: 64.2 f 18.6% versus 41 t 
12%, respectively (p < 0.05). 
During ergonovine-induced spasm, mean diameter of 
spastic segments was reduced by 91.5 ‘_ 17% (from 1.99 mm 
[mean control value in the four patients who received 
ergonovinel to 0.14 mm; p < 0.001). The extent of luminal 
reduction was significantly greater (p = 0.01) after adminis- 
tration of ergonovine compared with that during spontane- 
ous spasm. 
Behavior of nonspastic segments. Eighteen nonspastic 
segments were analyzed: two in each spastic vessel and 
another six (three proximal and three distal) in the circum- 
flex arteries of the three patients in whom spasm of the left 
anterior descending coronary artery developed (Fig. 1). 
Figure 2. Intraluminal coronary diameter of all spastic segments (A), 
proximal nonspastic segments (B) and distal nonspastic segments 
(C). Measurements in individual patients were obtained during 
control, spontaneous (Spont) spasm and ergonovine-induced (Ergo) 
spasm and after administration of intracoronary isosorbide dinitrate 
(ISDN). 
Conlrol Spent Ergo ISDN 
rp.ml 
COnlrd SfMxM Ergo ISDN 
.p.rm 
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Spastic Non-spastic Non-spastic 
segment proximal distal 
segment segment 
Figure 3. Percent change (average values) of coronary intraluminal 
diameter of spastic and nonspastic coronary segments during spon- 
taneous spasm and ergonovine-induced spasm and after administra- 
tion of intracoronary nitrates. 
During spontaneous spasm a diffuse and mild coronary 
constriction was observed in the nonspastic segments. Com- 
pared with control, luminal diameter of proximal nonspastic 
segments was reduced by 13.2 ? 7.5% (from 3.39 2 0.74 to 
2.99 _+ 0.88 mm; p < 0.01). Diameter of distal nonspastic 
segments was reduced by 14.8 ? 11% (from 2.79 ? 0.43 to 
2.38 ? 0.50 mm; p = 0.03) (Table 4, Fig. 2 and 3). The degree 
of coronary constriction observed during spontaneous 
spasm was not significantly different in nonspastic segments 
of the spastic vessel compared with segments located in 
unrelated arteries: 15.3 ? 8% versus 12.3 ? 9% reduction in 
caliber, respectively (p = 0.46). Moreover, the extent of 
constriction of proximal and distal nonspastic segments was 
also similar (p = 0.74) (Table 4, Fig. 3). Changes in caliber 
observed during spontaneous coronary spasm in the proxi- 
mal segments of nonspastic coronary arteries were also 
similar irrespective of the presence or absence of organic 
stenoses: during spontaneous spasm, the nonspastic coro- 
nary segments without detectable stenoses showed a 13 * 
7% reduction in luminal caliber and the nonspastic segments 
with obstructions of 12% to 40% showed a 14.7 ? 9% 
reduction (p = 0.76). 
During ergonovine-induced spasm, the extent of luminal 
diameter reduction of proximal nonspastic segments from 
control was not significantly different from that observed 
during spontaneous spasm: 17.7 + 9.8% versus 13.2 ? 7.5%; 
p = 0.52 (Table 4, Fig. 2 and 3). Luminal diameter of 
unrelated arteries was reduced by 17.75 ? 9% during er- 
gonovine-induced spasm. 
Effects of intracoronary nitrates on spastic and nonspastic 
segments. Intracoronary isosorbide dinitrate was adminis- 
tered to all patients to relieve either spontaneous (two 
patients) or ergonovine-induced spasm (four patients). After 
intracoronary isosorbide dinitrate, the coronary diameter of 
spastic segments increased by 20.7 t 23.9% compared with 
control (from 2.19 t 0.49 to 2.60 ? 0.55 mm) (Table 3, Fig. 
2 and 3). Coronary diameter of proximal and distal nonspas- 
tic segments increased by 18 + 13.5% and 16.5 ? 12%, 
respectively (Table 4, Fig. 3). Compared with control, dif- 
ferences observed between the coronary dilation of spastic 
and nonspastic segments after nitrate administration were 
not statistically significant (Fig. 3). All patients completed 
the study without occurrence of any untoward cardiac 
events. 
Discussion 
Mild, generalized vasoconstriction in the presence of severe 
focal spasm in variant angina. In this study we have 
documented, using computerized coronary arteriography, 
that in addition to the focal and exaggerated vasoconstriction 
that develops in the spastic segments during spontaneous 
spasm, a mild and diffuse vasoconstriction occurs in the 
remaining segments of the spastic artery and in the nonspas- 
tic coronary arteries in patients with Prinzmetal’s variant 
angina. Ergonovine-provoked focal spasm at the same site as 
spontaneous spasm but the extent of luminal narrowing 
Table 4. Changes in Luminal Diameter of Proximal and Distal Nonspastic Coronary Segments 
Proximal Nonspastic Segment 
Spontaneous Isosorbide 
Dinitrate 
Patient Control 
Spasm Ergonovine 
No. (mm) mm % Change mm % Change mm % Change 
1 3.24 2.1 -17 2.25 -30 4.04 25 
2 3.35 2.9 -14 ND ND 4.64 38 
3 3.44 2.65 -23 3.24 -6 3.62 5 
4 2.86 2.61 -1 2.31 -17 3.44 20 
5 4.78 4.13 -2 3.92 -18 4.84 1 
6 2.68 2.26 -16 ND ND 3.18 19 
Distal Nonspastic Segment 
Spontaneous Isosorbide 
Control 
Spasm Ergonovine Dinitrate 
(mm) mm % Change mm % Change mm % Change 
2.22 1.9 -I5 2.02 -8 2.49 12 
3.08 2.45 -20 ND ND 4.25 38 
3.26 2.42 -26 * * 2.8 14 
2.56 2.39 -7 * * 2.61 9 
3.13 3.24 3 2.61 -15 3.4 9 
2.46 1.87 -24 ND ND 3 22 
Mean 3.39 2.99 -13.17 2.95 -11.15 3.96 18.00 2.19 2.38 -14.83 2.35 -11.50 3.10 16.50 
SD 0.74 0.88 1.52 0.79 9.81 0.67 13.51 0.43 0.50 11.09 0.46 4.95 0.64 12.10 
*We were unable to measure segments distal to occlusive spasm. Abbreviations as in Table 3. 
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induced by this agent was greater, probably reflecting that 
different stimuli may elicit different degrees of response from 
the hyperreactive segment. Nonspastic segments during 
both spontaneous spasm and ergonovine-induced spasm, 
however, showed similar degrees of vasoconstriction. 
Our findings provide the first objective demonstration 
that spontaneous coronary spasm in patients with variant 
angina results from a local exaggerated constrictor response 
to a generalized stimulus, which produces only mild con- 
striction in both the remaining segments of the spastic vessel 
and in the nonspastic coronary arteries. The findings in our 
study are in agreement with the observations of Curry et al. 
(4), who noted mild, generalized epicardial coronary diame- 
ter reduction in some nonspastic segments during both 
spontaneous and ergonovine-induced spasm in patients with 
variant angina. These investigators, however, did not quan- 
tify the degree of coronary constriction that developed in 
spastic and nonspastic segments. 
Mechanism of coronary spasm in variant angina. Al- 
though the nature of the generalized vasoconstrictor stimu- 
lus is unknown, the demonstration of its effect on hyperre- 
active coronary segments and nonspastic arteries is 
important for the understanding of the mechanisms of coro- 
nary spasm in variant angina. indeed, for spontaneous 
coronary spasm to develop, both a hyperreactive coronary 
segment and a generalized constrictor stimulus affecting all 
coronary vessels appear to be necessary. We (3) and others 
(5-10) have shown that, in patients with variant angina, a 
large variety of different stimuli, and not a specific stimulus 
only, can produce coronary constriction to a degree similar 
to that produced in this study, thus indicating that a local 
nonspecific coronary hyperreactivity to different constric- 
tors is of paramount importance in the genesis of spasm in 
variant angina. This may explain why theories that propose 
specific receptor-agonist interactions involving parasympa- 
thetic (6), alpha-adrenergic (1 l-13), histaminergic (14) and 
serotonergic (IS) mechanisms or thromboxane A,-prostacy- 
clin imbalance ( 16) as the cause of coronary spasm could not 
be confirmed (15,17-24). It also explains why, although 
specific antagonists fail to prevent spasm (15,17-24), drugs 
that nonspecifically reduce the constrictor response of the 
coronary smooth muscle, such as nitrates and calcium 
antagonists, are effective for treatment of variant angina 
(25-28). 
Because constrictor stimuli are often present during or- 
dinary daily activities, changes of the ‘threshold” for spasm 
at the site of the hyperreactive segments are likely to play a 
major role in determining the frequency and severity of 
ischemic episodes in patients with variant angina. We pre- 
viously suggested that a variable susceptibility to spasm is 
present in variant angina because the dose of ergonovine 
required to provoke spasm in the same patient at different 
times is extremely variable (29). A variable susceptibility to 
spasm, within individuals, is also consistent with the fre- 
quent observation of active phases alternating with quies- 
cent periods or long-lasting remissions (30,31). During a 
quiescent period or during treatment with calcium antago- 
nists, spasm can sometimes be triggered by potent stimuli 
such as ergonovine; in most patients, however, the er- 
gonovine test also may become negative transiently or 
persistently (30-33). 
This study also demonstrates that focal coronary spasm 
does not result from the amplification of physiologic vaso- 
constriction at sites of subintimal plaques as proposed by 
MacAlpin (“geometric theory”) (34). Although focal spasm 
occurred consistently in association with atheromatous cor- 
onary narrowings, in our patients during spontaneous coro- 
nary spasm and as shown by Freedman et al. (35) during 
ergonovine challenge, the degree of vasoconstriction ob- 
served at the spastic segments far exceeded that predicted 
by the geometric theory, confirming the presence of a local 
coronary hyperreactivity. This is consistent with our find- 
ings during provoked coronary spasm (2,3) and also with 
recent observations of recurrence of spasm at the same 
arterial site over prolonged periods (36). 
Local coronary factors contributing to segmental spasm. 
The nature of the local coronary alteration that makes a 
particular coronary segment chronically hyperreactive to 
stimuli that cause only mild constriction in the other coro- 
nary arteries is not known. Certainly the syndrome of 
variant angina cannot be explained simply by the presence of 
an atheromatous plaque. Plaque rupture or fissuring is un- 
likely to be the cause of spontaneous spasm in the chronic 
forms of variant angina because this disease often remains 
relatively stable for months (30,37), as in the case of the six 
patients described in this study. Endothelial dysfunction 
caused only by a raised plaque is also an unlikely cause of 
local hyperreactivity because raised plaques were found to 
cover as much as 20% to 30% of the surface of epicardial 
coronary arteries of normal individuals who died in acci- 
dents (38). Furthermore, a local deficit of endothelium- 
derived relaxing factor (39) probably does not play a role in 
the genesis of variant angina; in experimental animals endo- 
thelial denudation alone was found to be insufficient to 
trigger coronary spasm (40). Increased numbers of specific 
receptors in certain segments of the coronary arteries also 
seems unlikely, because the spastic segments are hyperre- 
active to a large number of agonists (3). A postjunctional 
supersensitivity (41) of local arterial smooth muscle appears 
as a more attractive hypothesis. 
The finding in our patients that the dilator response to 
intracoronary nitrates was similar in spastic and nonspastic 
coronary segments is compatible with an abnormality con- 
fined to the constrictor response. The contrasting conclu- 
sions reached by Hill et al. (42), who observed that in 
patients with variant angina coronary segments involved in 
coronary spasm exhibited an exaggerated response to nitro- 
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glycerin, may be explained by an increased basal tone of the 
spastic segments in their patients. 
Conclusions. Spontaneous focal coronary spasm in pa- 
tients with variant angina results from the interaction be- 
tween a local coronary hyperreactivity, probably involving 
the smooth muscle locally, and the presence of a generalized 
stimulus that affects all coronary arteries, provoking com- 
plete vessel occlusion only at the site of the local hyperre- 
activity and only mild constriction in nonspastic arteries. 
Animal models (40,43) might provide insight into the basic 
mechanisms potentially responsible for the local coronary 
hyperreactivity in variant angina. 
Although focal coronary spasm as documented in this 
study is by far the most common clinical presentation of 
spasm in variant angina, the occasional observation of 
severe diffuse constriction involving all epicardial coronary 
arteries (44,45) may suggest that the interaction between the 
local hyperreactivity and constrictor stimuli may vary from 
patient to patient. 
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